Linde Plc SEC Filings

Linde plc reported stronger Q3 2025 results. Sales were $8,615 million, up from $8,356 million a year ago. Operating profit rose to $2,367 million from $2,086 million, and net income attributable to Linde increased to $1,929 million. Diluted EPS was $4.09 versus $3.22.

For the first nine months, operating cash flow reached $7,320 million, funding capital expenditures of $3,803 million, share repurchases of $3,205 million, and dividends of $2,113 million. Total debt was $25,925 million at September 30, 2025, up from $21,623 million at year‑end, reflecting new issuances including €850 million 2.625% notes due 2029, €750 million 3.00% notes due 2033, €650 million 3.25% notes due 2037, and CHF225 million 0.6150% notes due 2029 and CHF275 million 1.0629% notes due 2033; Linde also redeemed $600 million 4.700% notes and repaid $400 million 2.65% notes due 2025.

At September 30, 2025, cash and cash equivalents were $4,509 million and 466,948,930 ordinary shares were outstanding. Disclosed contingencies include $1.2 billion related to terminated Russian engineering projects with RCA and $0.7 billion tied to Amur GPP matters; proceedings and arbitrations remain ongoing.

Linde plc furnished an 8-K under Item 2.02 to announce results of operations for the quarter ended September 30, 2025. The company attached a press release dated October 31, 2025 as Exhibit 99.1, which is incorporated by reference.

Linde’s ordinary shares (nominal value €0.001) trade on the Nasdaq Stock Market under the symbol LIN.

Linde plc (LIN) reported an initial statement of beneficial ownership (Form 3) for its SVP, Americas, effective 10/22/2025. The officer holds 12,335.266 ordinary shares directly and 923.986 ordinary shares indirectly via a 401(k).

Reported derivative holdings include Restricted Stock Units for 1,064, 980, and 960 ordinary shares that vest and pay out on or about March 7, 2028, March 7, 2027, and March 7, 2026, respectively, on a one-for-one basis. Stock options are listed across multiple grants, including 7,468 options at an exercise price of $468.77 expiring 03/07/2035, and 6,340 options at $465.29 expiring 03/07/2034, each vesting in three equal annual installments beginning the March following grant. The filing also notes 240.682 deferred stock units payable one-for-one in ordinary shares under the company’s deferral plan.

The form was signed by Anthony M. Pepper as attorney-in-fact.

Guillermo Bichara, Executive Vice President & Chief Legal Officer of Linde plc (LIN), reported insider transactions dated 09/11/2025. The filing shows a gift disposition of 640 ordinary shares (transaction code G) with $0 received, reducing direct holdings to 22,137.769 ordinary shares. The report also discloses 2,890.178 shares held indirectly in a 401(k) plan. The Form 4 lists outstanding equity awards: restricted stock units totaling 4,863 RSUs scheduled to vest between 2026 and 2028, multiple stock options exercisable through 2035 representing specified share counts, and 794.534 deferred stock units payable one-for-one in ordinary shares under the company deferral plan.

Report summary: This Form 3 discloses initial beneficial ownership by Desiree Bacher, identified as SVP, Chief HR Officer of Linde plc (LIN). She directly holds 139 ordinary shares and beneficial ownership of multiple equity awards including restricted stock units, deferred stock units and stock options.

Specifically, the filing lists restricted stock units that will convert one-for-one to ordinary shares: 309 units vesting ~03/07/2028, 300 units vesting ~03/07/2027, and 260 units vesting ~03/07/2026. Stock options cover 2,168 shares exercisable beginning 03/07/2026 (strike $468.77), 1,920 shares beginning 03/07/2025 ($465.29), and 1,690 shares beginning 03/07/2024 ($354.14). There are also 40.669 deferred stock units under the Linde Compensation Deferral Plan.

Stephen F. Angel, a director of Linde plc (LIN), reported a change in beneficial ownership on Form 4. The filing shows a disposition on 08/18/2025 of 25,000 ordinary shares reported as a charitable gift with no market transaction and a $0 price. After the reported transaction the reporting person holds 455,542.502 ordinary shares directly and additional indirect holdings through trusts and a 401(k), including 71,029 shares via a 2010 Descendants Trust and other indirect interests. The filing also lists multiple outstanding restricted stock units and stock options with specified grant/expiration dates and share amounts.

Enders Thomas, a director of Linde plc (LIN), reported transactions dated 08/18/2025. The filing shows a gift of 2,500 ordinary shares (transaction code G) at a reported price of $0, leaving 10,594.803 ordinary shares beneficially owned following the transfer. The form also reports 467.02 restricted stock units (RSUs) that convert one-for-one into ordinary shares; those RSUs vest in full and pay out in shares one year after the March 7, 2025 grant date, subject to continuous board service with limited pro-rata exceptions. The Form 4 was signed by attorney-in-fact Anthony M. Pepper on 08/19/2025.

Linde plc (LIN) director Stephen F. Angel reported option exercise and share sales on 08/07/2025. The filing shows the acquisition of 125,000 ordinary shares via exercise and contemporaneous dispositions of 74,691 and 50,309 shares at weighted average sale prices reported as $474.94 and $473.38, respectively. The exercise price reported for the transactions is $118.71. The Form 4 lists aggregate post-transaction beneficial ownership totals shown as 605,542.502 shares (direct) and additional indirect holdings held in descendants' trusts, a 401(k) account and deferred share units. The filing is signed by an attorney-in-fact on 08/08/2025.